Cognitive Performance, Sociodemographic Factors, Pure-Tone Audiometry, and their Association with Speech Discrimination: A Prospective Population-Based Study of 1,061 Older Adults.
Journal
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504
Informations de publication
Date de publication:
01 10 2023
01 10 2023
Historique:
pmc-release:
01
10
2024
medline:
15
9
2023
pubmed:
25
8
2023
entrez:
25
8
2023
Statut:
ppublish
Résumé
Hearing loss is increasingly recognized as a chronic disease state with important health sequelae. Although considered a central component of routine audiometric testing, the degree to which various patient factors influence speech discrimination is poorly characterized to date. The primary objective of the current work was to describe associations of cognitive performance, sociodemographic factors, and pure-tone audiometry with speech discrimination in older adults. Prospective study. Olmsted County, Minnesota. There were 1,061 study participants 50 years or older at enrollment in the population-based Mayo Clinic Study of Aging between November 2004 and December 2019 who underwent formal audiometric and cognitive testing included in the current investigation. The primary outcome measure was word recognition scores (WRSs; measured as <100% vs 100% as well as continuous), with pure-tone averages (PTAs; 0.5, 1, 2, and 3 kHz), age, sex, years of education, state area deprivation index (ADI) quintiles, and global cognition z scores as explanatory features. The mean (SD) age among the 1,061 participants was 76 (9) years with 528 (50%) males. Participant age [OR (95% CI) for a 10-year increase of 1.8 (1.4-2.3), p < 0.001], male sex [OR = 2.6 (1.9-3.7), p < 0.001], and PTA [OR for a 10-dB hearing loss increase of 2.4 (2.1-2.8), p < 0.001] were all significantly associated with <100% WRSs, with the greatest explanatory ability attributable to the PTA. Years of education ( p = 0.9), state ADI quintile ( p = 0.6), and global cognitive performance ( p = 0.2) were not associated with WRS. The multivariable model demonstrated strong predictive ability for less than perfect WRSs, with a c index of 0.854. Similar results were seen for WRSs analyzed as continuous, with the multivariable model resulting in an R2 value of 0.433. Although PTA exhibited the greatest influence on speech discrimination, advancing age and male sex both independently increased the likelihood of having worse speech discrimination among older adults, even after accounting for years of education, neighborhood-level socioeconomic disadvantage, and cognitive function. These findings help identify patient factors that can be instrumental when designing screening programs for adult-onset hearing loss.
Identifiants
pubmed: 37621101
doi: 10.1097/MAO.0000000000004003
pii: 00129492-990000000-00394
pmc: PMC10529826
mid: NIHMS1919152
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
860-865Subventions
Organisme : NIA NIH HHS
ID : R01 AG041851
Pays : United States
Organisme : NIA NIH HHS
ID : R33 AG058738
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062677
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG058738
Pays : United States
Organisme : NIA NIH HHS
ID : R37 AG011378
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States
Informations de copyright
Copyright © 2023, Otology & Neurotology, Inc.
Déclaration de conflit d'intérêts
Conflicts of interest: R.C.P. has been a consultant for Roche, Biogen, Merck, Eisai, Genentech, and Nestle; receives publishing royalties from Mild Cognitive Impairment (Oxford University Press, 2003) and UpToDate; and receives research support from the U.S. National Institutes of Health. N.S.R. is on the advisory board of Neosensory and receives funding from the National Institutes of Health and the National Institute on Aging. M.V. has received research funding from F. Hoffmann-La Roche and Biogen in the past, consults for F. Hoffmann-La Roche, receives research funding from the National Institutes of Health, and has equity ownership in Abbott Laboratories, Johnson and Johnson, Medtronic, AbbVie, and Amgen. All other authors declare no competing interests.
Références
Ear Hear. 2016 Jul-Aug;37 Suppl 1:5S-27S
pubmed: 27355771
Otolaryngol Head Neck Surg. 2020 May;162(5):622-633
pubmed: 32151193
Horm Behav. 2009 Jan;55(1):98-105
pubmed: 18834887
Otol Neurotol. 2022 Sep 1;43(8):894-899
pubmed: 35900911
Lancet Healthy Longev. 2022 Dec;3(12):e817-e824
pubmed: 36410368
Horm Behav. 2006 Aug;50(2):285-92
pubmed: 16682033
Neuroepidemiology. 2008;30(1):58-69
pubmed: 18259084
Am J Audiol. 2019 Dec 16;28(4):1006-1014
pubmed: 31825642
N Engl J Med. 2018 Jun 28;378(26):2456-2458
pubmed: 29949490
JAMA Otolaryngol Head Neck Surg. 2018 Feb 1;144(2):115-126
pubmed: 29222544
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
Int J Audiol. 2005 Apr;44(4):213-30
pubmed: 16011050
J Neurosci. 2020 Aug 12;40(33):6357-6366
pubmed: 32690619
Ear Hear. 2016 Jul-Aug;37 Suppl 1:77S-84S
pubmed: 27355774
Clin Interv Aging. 2020 Dec 30;15:2453-2467
pubmed: 33408469
J Acoust Soc Am. 2004 Oct;116(4 Pt 1):2395-405
pubmed: 15532670
Front Aging Neurosci. 2022 Feb 28;13:769405
pubmed: 35295208
J Acoust Soc Am. 2019 Jun;145(6):3656
pubmed: 31255106
Cell Mol Life Sci. 2020 Feb;77(4):619-635
pubmed: 31522250
N Engl J Med. 2020 Apr 16;382(16):1531-1542
pubmed: 32294347
Mayo Clin Proc. 2012 Feb;87(2):151-60
pubmed: 22305027
Ear Hear. 2016 Jul-Aug;37 Suppl 1:44S-51S
pubmed: 27355769
Neurology. 2015 Apr 7;84(14):1433-42
pubmed: 25788555
Alzheimers Dement. 2022 Jun 6;:
pubmed: 35666244
Ann Otol Rhinol Laryngol. 2020 Apr;129(4):347-354
pubmed: 31735055
J Acoust Soc Am. 1995 Feb;97(2):1196-205
pubmed: 7876442
Otol Neurotol. 2020 Sep;41(8):1027-1032
pubmed: 32558754
Age Ageing. 2019 Nov 1;48(6):888-894
pubmed: 31437275
Int J Mol Sci. 2021 Jul 28;22(15):
pubmed: 34360877
J Am Acad Audiol. 2018 Jul/Aug;29(7):648-655
pubmed: 29988012
Otol Neurotol. 2022 Mar 1;43(3):e323-e330
pubmed: 35061637
Otolaryngol Head Neck Surg. 2012 Jul;147(1):102-4
pubmed: 22301102
JAMA Otolaryngol Head Neck Surg. 2020 Jul 1;146(7):613-620
pubmed: 32407461
Scand J Work Environ Health. 2010 May;36(3):250-7
pubmed: 20024522